Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
04/2012
04/19/2012CA2810999A1 Use of lysosomal acid lipase for treating lysosomal acid lipase deficiency in patients
04/18/2012EP2441466A1 Method for modulating appetite
04/18/2012EP2441463A1 Alkaline decomposition product of hop extract and use thereof
04/18/2012EP2441462A1 Method for treating type I diabetes
04/18/2012EP2441443A1 Lactoferrin based complex coacervates and their uses
04/18/2012EP2440577A1 Truncated actriib-fc fusion proteins
04/18/2012EP2440576A1 Methods for increasing thermogenic adipocytes
04/18/2012EP2440571A1 Production and use of antitumoral, antibiotic and insecticidal cyclodepsipeptides
04/18/2012EP2440569A1 Melanocortin receptor-specific peptides
04/18/2012EP2440563A1 Histamine h3 inverse agonists and antagonists and methods of use thereof
04/18/2012EP2440553A1 Thiophenes as glucagon receptor antagonists, compositions, and methods for their use
04/18/2012EP2440541A1 Novel fused cyclic compound and use thereof
04/18/2012EP2440537A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
04/18/2012EP2440521A1 Novel cyclopentane derivatives
04/18/2012EP2440246A2 Egfr and par2 regulation of intestinal permeability
04/18/2012EP2440241A1 Growth hormone polypeptides and methods of making and using same
04/18/2012EP2440235A1 Glp-1 and fgf21 combinations for treatment of diabetes type 2
04/18/2012EP2440233A1 Sorcs1-like agent for use in the treatment of insulin resistance and diseases related thereto
04/18/2012EP2440232A1 Glycomacropeptide medical foods for nutritional management of phenylketonuria and other metabolic disorders
04/18/2012EP2440228A1 Glucose-regulating polypeptides and methods of making and using same
04/18/2012EP2440223A1 Compositions and methods for increasing lifespan and health span
04/18/2012EP2440221A1 Composition used to prevent and treat red blood cell coagulation
04/18/2012EP2440219A2 Pharmaceutical compositions comprising extracts of sarcopoterium spinosum, components thereof, and uses thereof
04/18/2012EP2440217A1 Nutrition for improving muscle strength in elderly
04/18/2012EP2440201A1 Methods and compositions for treating insulin resistance, diabetes mellitus type 2, metabolic syndrome and related disorders
04/18/2012EP2440065A1 Copepod oil composition, formulations comprising the oil composition, and the use thereof to reduce accumulation of visceral fat, improve glucose tolerance, and prevent or treat obesity related diseases and disorders
04/18/2012EP2440049A1 Genotype specific methods for treating human subjects using 4- methylpyrazole
04/18/2012EP2197477B1 Use of lvv-hemorphin-6 and optionally af12198 as therapeutic agent(s)
04/18/2012EP2188286B1 Process for the preparation of pyrido [2, 1-a]isoquinoline derivatives
04/18/2012EP2094705B1 Azabicyclic heterocycles as cannabinoid receptor modulators
04/18/2012EP1598346B1 Process for producing acid adduct salt of polyacidic base compound
04/18/2012EP1499358B1 Ph-sensitive polymer
04/18/2012EP1333846B1 Preparation and xenotransplantation or porcine islets
04/18/2012EP1284724B1 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
04/18/2012CN1785284B Medicinal composition containing flowery knotwood root
04/18/2012CN102421798A Compositions and methods of use for binding molecules to dickkopf-1 or dickkopf-4 or both
04/18/2012CN102421784A 作为gsk-3抑制剂的7-环烷基氨基喹诺酮 As gsk-3 inhibitor 7-cyclic alkyl amino quinolone
04/18/2012CN102421777A 作为hsl抑制剂的氮杂环螺衍生物 As hsl inhibitors spiro heterocyclic derivatives
04/18/2012CN102421774A 新型异喹啉衍生物 The new isoquinoline derivatives
04/18/2012CN102421773A Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
04/18/2012CN102421760A Dihydropyrimidinones for use as bace2 inhibitors
04/18/2012CN102421739A 羧酸化合物 Carboxylic acid compound
04/18/2012CN102421439A 以来自鸟皮的鞘磷脂含有物为有效成分的抗高血糖和/或抗高血脂症剂 Sphingomyelin-containing material from the skin of birds is an active ingredient of anti-hyperglycemic and / or anti-hyperlipidemia agent,
04/18/2012CN102421424A Combination therapies for treating metabolic disorders
04/18/2012CN102417508A 作为新陈代谢调节剂的稠合芳基和杂芳基衍生物以及预防和治疗与其相关的病症 A fused aryl and heteroaryl metabolic modulators aryl derivatives and the prevention and treatment of disorders associated therewith
04/18/2012CN102417483A 作为parp抑制剂的2-苯基-1h-苯并咪唑-4-甲酸酯衍生物 As parp inhibitors -1h- benzimidazole-2-phenyl-4-ester derivative
04/18/2012CN102417480A Spirocyclic nitriles as protease inhibitors
04/18/2012CN102416138A 一种具有解酒降脂养胃作用的组合物及其制备方法 Lipid composition having a hangover effect and its preparation method Stomach
04/18/2012CN102416112A 一种治疗消渴病的中药组合物 A therapeutic herbal composition Diabetes
04/18/2012CN102416107A 一种治疗脑血管疾病的药物 A method of treating cerebral vascular diseases
04/18/2012CN102416104A 一种养生保健的药物及其制备方法 One kind of health care and preparation method
04/18/2012CN102416072A 一种油茶皂苷控释片及其制备方法 One kind sasanquasaponin GITS its preparation method
04/18/2012CN102416056A 一种降血脂复方纳米乳口服液及其制备方法 One kind of oral lipid nanoemulsion compound and its preparation method
04/18/2012CN102416042A 一种调压降脂、软化动脉和保心护脑的制剂及其制备方法 A lipid-lowering, soften and protect heart arteries protect the brain and its preparation method regulator
04/18/2012CN102416030A 一种万寿菊干花颗粒的生产方法 A method of producing dried marigold particles
04/18/2012CN102416029A Ginseng submicron powder and preparation method and preparation thereof
04/18/2012CN102416007A 一种盐酸二甲双胍肠溶胶囊 One kind of metformin hydrochloride enteric-coated capsules
04/18/2012CN102416004A 格列美脲片及其制备方法 Glimepiride tablets and its preparation method
04/18/2012CN102415999A 一种通过白蛋白纳米粒吸附灯盏花素制备的灯盏花素白蛋白纳米粒 A prime preparation of albumin nanoparticles adsorbed by albumin nanoparticles Dengzhanhua Breviscapine
04/18/2012CN102415986A 含磷脂和胆盐的难溶性药物固体分散体及其制备方法 Phospholipid containing a poorly soluble drug and bile solids dispersion and its preparation method
04/18/2012CN102415963A 一种减肥霜的制作方法 A method of making creams
04/18/2012CN102078492B 一种复方白芍制剂的制备方法及其用途 A COMPOUND peony preparation methods of preparation and use thereof
04/18/2012CN102078418B Compound traditional Chinese medicine extract for preventing and treating lipid metabolism disorder and preparation method thereof
04/18/2012CN102058537B 一种谷维素固体分散体组合物及其制剂 One kind oryzanol solid dispersion compositions and preparations
04/18/2012CN101933919B 棕矢车菊素的用途 Brown cyanidin use
04/18/2012CN101904907B 富含肌醇和总黄酮的荞麦提取物、制备方法及其用途 Rich in inositol and total flavonoids of buckwheat extract, preparation and use
04/18/2012CN101884739B Food therapy preparation for preventing and treating diabetes based on theories of preventive treatment of disease and medicine food homology
04/18/2012CN101884735B 一种治疗血脂异常的药物及其制备方法 A dyslipidemia and preparation method of treatment
04/18/2012CN101884412B 一种天然复合氨基酸螯合钙的制备方法 Preparation method of natural calcium amino acid chelate complex
04/18/2012CN101879193B 具有抑制α-葡萄糖苷酶和黄嘌呤氧化酶作用的中药组合物及其制备方法和用途 Α- glucosidase inhibiting xanthine oxidase and the role of traditional Chinese medicine composition and its preparation method and uses
04/18/2012CN101851624B 胰高血糖素受体基因的rna干扰序列 Glucagon receptor interference rna gene sequence
04/18/2012CN101828660B 一种用于高血糖病人的保健食品 Health food for hyperglycemic patients
04/18/2012CN101822751B 一种茶精华素软胶囊及其制备方法 One kind of tea essence soft capsule and its preparation method
04/18/2012CN101647840B 用于控制代谢症候群的中草药组成物及其制备方法 Control of metabolic syndrome herbal composition and preparation methods for
04/18/2012CN101579343B Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
04/18/2012CN101560179B 具有H<sub>3</sub>受体亲和能力的含氮吲哚衍生物和用途 Having H <sub> 3 </ sub> receptor affinity and capacity and use of nitrogen-containing indole derivatives
04/18/2012CN101530517B 一种治疗中心性肥胖和非酒精性脂肪肝的中药复方及其制备方法 A central obesity and nonalcoholic fatty liver treatment of traditional Chinese medicine and its preparation method
04/18/2012CN101439143B 一种含知母提取物的中药颗粒及其制备方法 Chinese medicine granules and its preparation method extracts containing Anemarrhena
04/18/2012CN101367834B 用于制备醇和酚的水溶性膦酰氧基甲基衍生物的方法 A water-soluble phosphine acyloxymethyl derivatives of alcohols and phenols used in the preparation of
04/18/2012CN101289477B 一种n-苯丙烯酰基壳寡糖及其制备 One kind n- benzene and preparation acryloyl Oligochitosan
04/18/2012CN101199689B 一种葡菊胶囊及其制备方法 One kind of grape Ju capsule and its preparation method
04/18/2012CN101165052B 作为载脂蛋白b分泌抑制剂的n-芳基六氢吡啶取代的联苯基羧酰胺 As apolipoprotein b secretion inhibitors n- aryl-piperidine-substituted biphenyl-carboxamide
04/17/2012US8158750 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor
04/17/2012US8158661 GSK-3 inhibitors
04/17/2012US8158634 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
04/17/2012US8158617 Fused heterocyclic compound and use thereof
04/17/2012US8158585 Controlling extracellular protein degradation and/or clearance via modulation of tissue plasminogen activator activity; treating diabetic, autoimmune, cardiovascular, blood and nervous system disorders
04/17/2012US8158171 Methods of lowering blood cholesterol via oral fenugreek seed extract compositions
04/17/2012CA2702047C Substituted biphenyl gpr40 modulators
04/17/2012CA2695291C Substituted bicyclolactam compounds
04/17/2012CA2662305C Heterocyclic gpr40 modulators
04/17/2012CA2629670C Scored dosage form allowing modified release of the active ingredient
04/17/2012CA2582447C Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
04/17/2012CA2517429C Process for manufacturing a pharmaceutical composition in the form of tablets containing a fibrate and the tablets obtained through the process
04/17/2012CA2513717C Novel use of mifepristone and derivatives thereof as hedgehog protein signalling pathway modulators and applications of same
04/17/2012CA2498636C Use of saccharomyces cerevisiae erg4 mutants for the expression of glucose transporters from mammals
04/17/2012CA2487699C A buffered, liquid nicotine composition for pulmonary administration
04/17/2012CA2402894C Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase iv and method
04/17/2012CA2363958C Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction
04/17/2012CA2361070C Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid
1 ... 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 ... 1298